Form 4 for BENF Beneficient

Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001493152-24-047671 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-11-25	2024-11-21	BENF	Wendel Karen	Dir	A - Grant	$0.00	+207.3K	207.3K	New	$0
D	2024-11-25	2024-11-21	BENF	Wendel Karen	Dir	A - Grant	$0.00	+100.0K	100.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-11-21	A	A	207,317	$0.00	207,317	D	—	—	(F1) Includes 207,317 shares of Class A common stock, par value $0.001 ("Class A common stock"), of Beneficient (the "Issuer") issuable upon the settlement of an award of 207,317 restricted stock units ("RSUs") granted pursuant to the Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Karen Wendel (the "Reporting Person") on November 21, 2024. Such award of RSUs to the Reporting Person will vest in four equal installments on the last day of each calendar quarter over a one-year period from the date of grant, provided that the Reporting Person is providing services to the Issuer through each applicable vesting date.
2	Derivative	Stock Option (Right to Buy)	2024-11-21	A	A	100,000	$0.00	100,000	D	$0.82 · 2024-12-31 to 2034-11-20	100,000 Class A Common Stock	(F2) The shares underlying this stock option were granted pursuant to the 2023 Equity Incentive Plan and will vest and become exercisable in eight equal installments on the last day of each calendar quarter over a two-year period from the date of grant, provided that the Reporting Person is providing services to the Issuer through each applicable vesting date.